MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 05-06-2026
Smith & Nephew plc Gross Profit 2011-2026 | SNN
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.19 B | 4.05 B | 3.82 B | 3.68 B | 3.67 B | 3.16 B | 3.8 B | 3.61 B | 3.52 B | 3.4 B | 3.49 B | 3.46 B | 3.25 B | 3.07 B | 3.13 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.19 B | 3.07 B | 3.55 B |
Quarterly Gross Profit Smith & Nephew plc
| 2025-Q4 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.19 B | 4.05 B | 3.82 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.19 B | 3.82 B | 4.02 B |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
275 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 11.47 | 0.26 % | $ 325 M | USA |
 |
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
532 M | $ 8.15 | -1.39 % | $ 1.22 B | USA |
 |
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
26.6 M | $ 4.34 | 0.93 % | $ 162 M |  France |
 |
BioSig Technologies
BSGM
|
18 K | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.52 M | $ 2.27 | -0.87 % | $ 50 M | USA |
 |
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 1.02 | 1.49 % | $ 17.3 M | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 0.47 | 2.17 % | $ 29.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 17.93 | -2.37 % | $ 421 M | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 10.9 | -1.11 % | $ 390 M | USA |
 |
LENSAR
LNSR
|
14.1 M | $ 5.95 | -2.3 % | $ 71.2 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
940 M | $ 75.12 | 1.74 % | $ 4.1 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
67.1 M | $ 1.53 | -1.61 % | $ 62.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
346 M | $ 3.69 | 1.8 % | $ 545 M | USA |
 |
Electromed
ELMD
|
50 M | $ 37.76 | -1.2 % | $ 319 M | USA |
 |
Myomo
MYO
|
26.9 M | $ 1.02 | -1.44 % | $ 42.7 M | USA |
 |
Butterfly Network
BFLY
|
45.7 M | $ 4.54 | 1.57 % | $ 1.12 B | USA |
 |
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
566 M | $ 9.6 | -10.7 % | $ 380 M |  Curacao |
 |
GBS
GBS
|
1.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.02 B | $ 85.26 | 0.53 % | $ 11.5 B | USA |
 |
Profound Medical Corp.
PROF
|
11.4 M | $ 6.9 | 1.02 % | $ 209 M | Canada |
 |
Insulet Corporation
PODD
|
1.94 B | $ 154.04 | -0.53 % | $ 10.8 B | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 36.03 | -3.21 % | $ 1.12 B | USA |
 |
Sintx Technologies
SINT
|
461 K | $ 2.41 | 0.67 % | $ 6.68 M | USA |
 |
Inspire Medical Systems
INSP
|
779 M | $ 42.5 | -3.06 % | $ 1.25 B | USA |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 90.14 | 0.96 % | $ 3.13 B | USA |
 |
Invacare Corporation
IVC
|
48.3 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 87.4 | 1.89 % | $ 51.1 B | USA |
 |
TransMedics Group
TMDX
|
363 M | $ 69.63 | 1.01 % | $ 2.37 B | USA |